Main navigation
Search Results
-
-
-
-
The Baden-Württemberg healthcare industry https://www.gesundheitsindustrie-bw.de/en/facts-and-figuresAt a glance
-
The Baden-Württemberg healthcare industry https://www.gesundheitsindustrie-bw.de/en/location/pharmaThe pharmaceutical industry
-
The Baden-Württemberg healthcare industry https://www.gesundheitsindustrie-bw.de/en/location/medtechMedical technology
-
The Baden-Württemberg healthcare industry https://www.gesundheitsindustrie-bw.de/en/location/biotechThe biotechnology sector
-
-
Article - 01/03/2017 https://www.gesundheitsindustrie-bw.de/en/database/detailsDetails
-
Database - 21/04/2016 https://www.gesundheitsindustrie-bw.de/en/database/fundingFunding
-
Expert interview - 16/01/2019 Cybersecurity is an important issue for the pharmaceutical industry
In an increasingly interconnected world, the pharmaceutical and biotechnology sectors need to be aware of cybersecurity threats in manufacturing. We talked about these threats with Holger Mettler who is in charge of computer system validation and cybersecurity at Exyte (formerly M + W), a global enterprise that designs, engineers and constructs complex manufacturing facilities and buildings for the life sciences industry.
https://www.gesundheitsindustrie-bw.de/en/article/news/cybersecurity-is-an-important-issue-for-the-pharmaceutical-industry -
The Baden-Württemberg healthcare industry https://www.gesundheitsindustrie-bw.de/en/location/infrastructureInfrastructure
-
The Baden-Württemberg healthcare industry https://www.gesundheitsindustrie-bw.de/en/location/start-upCompany foundation
-
Company profile - 09/01/2019 HQS Quantum Simulations for industrial quantum mechanics applications
The door to the quantum world is opening wider and wider. Behind it is a whole new view of materials and molecules. Quantum mechanics applications not only benefit science, they also offer huge economic potential. The Karlsruhe start-up HQS Quantum Simulations is playing a pioneering role in quantum simulations for the chemical and pharmaceutical industries.
https://www.gesundheitsindustrie-bw.de/en/article/news/hqs-quantum-simulations-for-industrial-quantum-mechanics-applications -
The Baden-Württemberg healthcare industry https://www.gesundheitsindustrie-bw.de/en/location/location-bwLocation BW
-
-
-
-
Article - 18/03/2019 EHR and PHR: digital records in the German healthcare system
EHRs, i.e. electronic health records (German: Patientenakte, ePA), are hailed as the key to increasing the quality of care. The Appointment Service and Supply Act (TSVG), adopted on 14th March 2019, requires the German statutory health insurance funds to provide policyholders with electronic health records from 1st January 2021 onwards.
https://www.gesundheitsindustrie-bw.de/en/article/news/ehr-and-phr-digital-records-in-the-german-healthcare-system -
Article - 28/03/2019 Supporting the human use of artificial intelligence
Artificial intelligence is no longer a vision of the future, but is already in our midst: whether it is parking aids or search engines, we use the technology quite naturally in many areas of daily life. It promises new, unlimited opportunities, but also poses risks. Experts from the Integrata Foundation in Tübingen work on ethical issues and the human use of IT for improving the life of as many people as possible.
https://www.gesundheitsindustrie-bw.de/en/article/news/supporting-the-human-use-of-artificial-intelligence -
Article - 24/01/2019 Scientists to combat antibiotic-resistant bacteria in wastewater
In Germany, around 1,500 tonnes of antibiotics per year are administered to humans and animals. As a result, more and more bacteria are developing resistance to common antibiotics. As part of HyReKA, a cooperative project funded by the BMBF, scientists led by Professor Thomas Schwartz from the KIT are investigating how antibiotic-resistant pathogens spread and how they can be prevented from doing so.
https://www.gesundheitsindustrie-bw.de/en/article/news/scientists-to-combat-antibiotic-resistant-bacteria-in-wastewater -
Article - 29/01/2019 Targeted RNA editing with the body’s own enzyme activity
Completely new possibilities for research and gene therapy became available following the development of the CRISPR/Cas method for targeted modification of the genome. However, treatment with molecular scissors is not without risk as potential errors are stored in the genome forever. Scientists from Tübingen have developed an alternative method in which the intervention takes place at the RNA level using the body's own enzymes and is thus…
https://www.gesundheitsindustrie-bw.de/en/article/news/targeted-rna-editing-with-the-bodys-own-enzyme-activity -
Article - 22/03/2019 Personalised therapies for treating metastasing breast cancer
Breast cancer is characterised by broad genetic diversity. Successful treatment is made even more difficult by the fact that, in advanced breast cancer, the properties of metastases often differ significantly from the primary tumour. The Heidelberg CATCH study is now collecting genetic profiles from patients' metastasis tissue samples, which can be used to tailor therapy to individual requirements.
https://www.gesundheitsindustrie-bw.de/en/article/news/personalisierte-therapieansaetze-bei-metastasiertem-brustkrebs -
Article - 21/02/2019 Using neuromedical artificial intelligence responsibly
Brain-computer interfaces are the latest developments in the neurotechnology field. They are used to record brain activity, which is then decoded with artificial intelligence techniques and converted into control signals for robots or computers. While this brings hope to severely paralysed people, it also implies risks due to the interest of companies like Google and Facebook in this type of data.
https://www.gesundheitsindustrie-bw.de/en/article/news/using-neuromedical-artificial-intelligence-responsibly -
Article - 07/02/2019 Artificial intelligence in ophthalmology
Retinal diseases such as age-related macular degeneration (AMD) are now treatable. However, it is hard to predict individual disease progression. A group of researchers at the University Eye Centre in Freiburg are currently developing a new system which is hoped will allay fears and improve therapy planning. The system uses artificial intelligence to predict therapeutic outcome from image and patient data. Initial results are already available.
https://www.gesundheitsindustrie-bw.de/en/article/news/artificial-intelligence-in-ophthalmology